By Peter Nurse
Investing.com -- Stocks in focus in premarket trade on Thursday, September 23rd. Please refresh for updates.
-
Pfizer (NYSE:PFE) stock rose 0.8% after the Food and Drug Administration approved the drugmaker’s booster shots of its Covid-19 vaccine for older people and other vulnerable Americans.
-
Darden Restaurants (NYSE:DRI) stock rose 4.2% after the owner of Olive Garden and Longhorn Steakhouse reported strong first-quarter results and raised its 2022 outlook, as well declaring a quarterly dividend and an additional $750 million stock buyback.
-
Rite Aid (NYSE:RAD) stock fell 3.8% after the chain of pharmacies reported a hefty second quarter net loss from continuing operations of over $100 million, even as the company raised its full-year earnings guidance.
-
Salesforce (NYSE:CRM) stock rose 2.3% following the software company lifting its full-year revenue outlook and offering up upbeat 2023 guidance.
-
Facebook (NASDAQ:FB) stock rose 0.7%, rebounding after Wednesday’s 4% loss, following comments from marketing head Graham (NYSE:GHM) Mudd that the social media giant is under-reporting the results of its business on Apple (NASDAQ:AAPL) devices. This lessened worries associated with changes to the iPhone maker's privacy rules.
-
Blackberry (TSX:BB) stock rose 8% after the handheld device maker, and occasional meme favorite, reported better-than-expected second-quarter results, helped by demand for Internet of Things solutions.
-
Biogen (NASDAQ:BIIB) stock rose 0.8% on the back of investment firm Needham sticking with its ‘buy’ rating for the biotech company, saying the stock market has not priced in the potential upside for new drugs.
-
HB Fuller (NYSE:FUL) stock rose 2.7% after the chemicals company reported better-than-expected organic revenue growth, climbing by double digits.
-
Roku (NASDAQ:ROKU) stock rose 2.8%, helped by Guggenheim upgrading its investment stance to ‘buy’ from ‘neutral’, citing the streaming hardware company's inroads into the international market.